NCT01772329View on ClinicalTrials.gov

Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2020

Study Completion Date

October 31, 2020

Conditions
Catastrophization
Interventions
OTHER

Cognitive Therapy

CT will be used as a preemptive treatment in an effort to minimize the effects of catastrophic thinking.

OTHER

Routine Care

Routine Care. No Cognitive Therapy Intervention

Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Rush University Medical Center

OTHER

NCT01772329 - Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects | Biotech Hunter | Biotech Hunter